BD-29-IQ20_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, Tyrphostin AG 555, CDK2 Inhibitors;Tyrosine Kinase Inhibitors targeting CDK2 (Novartis, 5328770)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/5328770
Similar Terms
Downloads & Tools

Genes

16 genes differentially expressed following the BD-29-IQ20_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
PPDPF pancreatic progenitor cell differentiation and proliferation factor 0.55582
CDC20 cell division cycle 20 0.345393
RPS11 ribosomal protein S11 0.252951
GUSB glucuronidase, beta 0.207146

decreased expression

Symbol Name Standardized Value
PRIM2 primase, DNA, polypeptide 2 (58kDa) -0.368231
VPS41 vacuolar protein sorting 41 homolog (S. cerevisiae) -0.340949
RYBP RING1 and YY1 binding protein -0.298044
CHML choroideremia-like (Rab escort protein 2) -0.270803
ARFGEF2 ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) -0.268589
MED21 mediator complex subunit 21 -0.258504
CYB5B cytochrome b5 type B (outer mitochondrial membrane) -0.238238
GFM2 G elongation factor, mitochondrial 2 -0.223396
ARID4B AT rich interactive domain 4B (RBP1-like) -0.223396
CPPED1 calcineurin-like phosphoesterase domain containing 1 -0.212926
BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) -0.212926
NCOA4 nuclear receptor coactivator 4 -0.206958